✦ LIBER ✦

A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma

✍ Scribed by Annie Mathew; Hwee-Ming Cheng; Choon-Kook Sam; Irene Joab; Umapati Prasad; Chantal Cochet

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 353 KB
Volume: 38
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01517172

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Linear epitopes of the replication-activ

Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma

✍ Hwee-Ming Cheng; Yoke-Ting Foong; Aini J. AbuSamah; Joakim Dillner; Choon-Kook S 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 579 KB

Significance of Specific Epstein-Barr Vi

Significance of Specific Epstein-Barr Virus IgA and Elevated IgG Antibodies to Viral Capsid Antigens in Nasopharyngeal Carcinoma Patients

✍ Tuvia Hadar; Jack Sidi; Menashe Rahima; Erika Rakowsky; Ernesto Kahan; Batya Sar 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

The feasibility of using elevated Epstein-Barr virus (EBV) specific-IgG antiviral capsid antigen (VCA) and IgA anti-VCA antibody levels as an aid in diagnosis of nasopharyngeal carcinoma (NPC) was analyzed by determination of serum antibody titers to EBV in 54 NPC patients, 114 healthy blood donors,

Antibodies to the Epstein-Barr virus tra

Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma

✍ R'kia Dardari; Meriem Khyatti; Abdellatif Benider; Hassan Jouhadi; Abdelouahad K 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 54 KB 👁 2 views

Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) generally occurs in adults, especially in high-prevalence populations such as the Chinese and Eskimos. In Maghrebian populations, young patients affected with this malignancy represent 25% of the total NPC cases. In adults with NPC,

Antibody response to Epstein–Barr virus

Antibody response to Epstein–Barr virus Rta protein in patients with nasopharyngeal carcinoma : A new serologic parameter for diagnosis

✍ Ping Feng; Soh Ha Chan; Mei Yun Rachel Soo; Dingxiang Liu; Ming Guan; Ee Chee Re 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

Antibodies to Epstein-Barr virus thymidi

Antibodies to Epstein-Barr virus thymidine kinase: A characteristic marker for the serological detection of nasopharyngeal carcinoma

✍ Yvonne Connolly; Edward Littler; Ning Sun; Xiaoyi Chen; Pei-Chun Huang; Simon N. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

Antibody against the Epstein-Barr virus

Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma

✍ Liu, Mei-Ying; Shih, Ya-Yi; Chou, Sheng-Ping; Chen, Chien-Jen; Sheen, Tzung-Shia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

The Epstein-Barr virus (EBV) open reading frame BHRF1, a homologue of the oncogene bcl-2, was cloned from a patient with nasopharyngeal carcinoma (NPC) and overexpressed in Escherichia coli. The resulting recombinant BHRF1 fusion protein, with an apparent molecular weight of 35 KD, was used as antig